Abstract:BackgroundUnambiguous HLA typing is important in hematopoietic stem cell transplantation (HSCT), HLA disease association studies, and solid organ transplantation. However, current molecular typing methods only interrogate the antigen recognition site (ARS) of HLA genes, resulting in many cis-trans ambiguities that require additional typing methods to resolve. Here we report high-resolution HLA typing of 10,063 National Marrow Donor Program (NMDP) registry donors using long-range PCR by next generation sequencing (NGS) approach on buccal swab DNA.MethodsMultiplex long-range PCR primers amplified the full-length of HLA class I genes (A, B, C) from promotor to 3' UTR. Class II genes (DRB1, DQB1) were amplified from exon 2 through part of exon 4. PCR amplicons were pooled and sheared using Covaris fragmentation. Library preparation was performed using the Illumina TruSeq Nano kit on the Beckman FX automated platform. Each sample was tagged with a unique barcode, followed by 2x250 bp paired-end sequencing on the Illumina MiSeq. HLA typing was assigned using Omixon Twin software that combines two independent computational algorithms to ensure high confidence in allele calling. Consensus sequence and typing results were reported in Histoimmunogenetics Markup Language (HML) format. All homozygous alleles were confirmed by Luminex SSO typing and exon novelties were confirmed by Sanger sequencing.ResultsUsing this automated workflow, over 10,063 NMDP registry donors were successfully typed under high-resolution by NGS. Despite known challenges of nucleic acid degradation and low DNA concentration commonly associated with buccal-based specimens, 97.8% of samples were successfully amplified using long-range PCR. Among these, 98.2% were successfully reported by NGS, with an accuracy rate of 99.84% in an independent blind Quality Control audit performed by the NDMP. In this study, NGS-HLA typing identified 23 null alleles (0.023%), 92 rare alleles (0.091%) and 42 exon novelties (0.042%).ConclusionLong-range, unambiguous HLA genotyping is achievable on clinical buccal swab-extracted DNA. Importantly, full-length gene sequencing and the ability to curate full sequence data will permit future interrogation of the impact of introns, expanded exons, and other gene regulatory sequences on clinical outcomes in transplantation.

Evaluation of HLA typing content of next-generation sequencing datasets from family trios and individuals of arab ethnicity

Benchmarking freely available HLA typing algorithms across varying genes, coverages and typing resolutions

Benchmarking the Human Leukocyte Antigen Typing Performance of Three Assays and Seven Next-Generation Sequencing-Based Algorithms

High-sensitivity HLA typing by Saturated Tiling Capture Sequencing (STC-Seq)

Application Of High-Throughput Next-Generation Sequencing For Hla Typing On Buccal Extracted Dna: Results From Over 10,000 Donor Recruitment Samples

Investigating the genetic makeup of the major histocompatibility complex (MHC) in the United Arab Emirates population through next-generation sequencing

P100: LONG RANGE NGS HLA TYPING IS ACCURATE IN THE IDENTIFICATION OF COMMON, RARE, AND NOVEL ALLELES

A rigorous benchmarking of alignment-based HLA typing algorithms for RNA-seq data

High resolution HLA genotyping with third generation sequencing technology-A multicentre study

P011 Advances in HLA Clinical Relevant Exon Novelty Detection from over 21,000 Donor Recruitment Samples

HLA genotyping in the clinical laboratory: comparison of next-generation sequencing methods

Next-generation Sequencing for HLA Typing of Class I Loci.

Unambiguous Hla Genotyping Using Long-Range Pcr and Next-Generation Sequencing (ngs) on Buccal-Extracted Dna: Results from 4000 Donor Recruitment Samples.

Application of High-Throughput, High-Resolution and Cost-Effective Next Generation Sequencing-Based Large-Scale Hla Typing in Donor Registry

Single locus HLA sequencing with the nanopore technology for HLA disease association diagnosis

Lessons Learned from Expanded Reproductive Carrier Screening in Self‐reported Ashkenazi, Sephardi, and Mizrahi Jewish Patients

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

HLA allele-calling using multi-ancestry whole-exome sequencing from the UK Biobank identifies 129 novel associations in 11 autoimmune diseases

Advancements in HLA Typing Techniques and Their Impact on Transplantation Medicine

Evaluation of next generation sequencing platforms for population targeted sequencing studies

Extending HLA allele sequences using next‐generation sequencing technology